209 related articles for article (PubMed ID: 11145457)
1. Effectiveness of different vaccine formulations against vibriosis caused by Vibrio vulnificus serovar E (biotype 2) in European eels Anguilla anguilla.
Collado R; Fouz B; Sanjuán E; Amaro C
Dis Aquat Organ; 2000 Nov; 43(2):91-101. PubMed ID: 11145457
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a bivalent vaccine against eel diseases caused by Vibrio vulnificus after its administration by four different routes.
Esteve-Gassent MD; Fouz B; Amaro C
Fish Shellfish Immunol; 2004 Feb; 16(2):93-105. PubMed ID: 15123314
[TBL] [Abstract][Full Text] [Related]
3. Field testing of a vaccine against eel diseases caused by Vibrio vulnificus.
Fouz B; Esteve-Gassent MD; Barrera R; Larsen JL; Nielsen ME; Amaro C
Dis Aquat Organ; 2001 Aug; 45(3):183-9. PubMed ID: 11558727
[TBL] [Abstract][Full Text] [Related]
4. Route of vaccine administration: effects on the specific humoral response in rainbow trout Oncorhynchus mykiss.
Palm RC; Landolt ML; Busch RA
Dis Aquat Organ; 1998 Jul; 33(3):157-66. PubMed ID: 9745714
[TBL] [Abstract][Full Text] [Related]
5. Immunological evaluation of Vibrio alginolyticus, Vibrio harveyi, Vibrio vulnificus and infectious spleen and kidney necrosis virus (ISKNV) combined-vaccine efficacy in Epinephelus coioides.
Huang Z; Tang J; Li M; Fu Y; Dong C; Zhong JF; He J
Vet Immunol Immunopathol; 2012 Nov; 150(1-2):61-8. PubMed ID: 23010220
[TBL] [Abstract][Full Text] [Related]
6. A multivalent killed whole-cell vaccine induces effective protection against Edwardsiella tarda and Vibrio anguillarum.
Sun Y; Liu CS; Sun L
Fish Shellfish Immunol; 2011 Oct; 31(4):595-9. PubMed ID: 21763772
[TBL] [Abstract][Full Text] [Related]
7. Construction and evaluation of a live vaccine against Edwardsiella tarda and Vibrio harveyi: laboratory vs. mock field trial.
Hu YH; Cheng S; Zhang M; Sun L
Vaccine; 2011 May; 29(24):4081-5. PubMed ID: 21514342
[TBL] [Abstract][Full Text] [Related]
8. Immunization of a novel bivalent outer membrane protein simultaneously resisting Aeromonas hydrophila, Edwardsiella anguillarum and Vibrio vulnificus infection in European eels (Angullia angullia).
Guo S; He L; Wu L; Xiao Y; Zhai S; Yan Q
Fish Shellfish Immunol; 2020 Feb; 97():46-57. PubMed ID: 31846771
[TBL] [Abstract][Full Text] [Related]
9. A bivalent Vibrio harveyi DNA vaccine induces strong protection in Japanese flounder (Paralichthys olivaceus).
Hu YH; Sun L
Vaccine; 2011 Jun; 29(26):4328-33. PubMed ID: 21513763
[TBL] [Abstract][Full Text] [Related]
10. A novel recombinant bivalent outer membrane protein of Vibrio vulnificus and Aeromonas hydrophila as a vaccine antigen of American eel (Anguilla rostrata).
SongLin G; PanPan L; JianJun F; JinPing Z; Peng L; LiHua D
Fish Shellfish Immunol; 2015 Apr; 43(2):477-84. PubMed ID: 25655329
[TBL] [Abstract][Full Text] [Related]
11. Protective efficiency of DNA vaccination in Asian seabass (Lates calcarifer) against Vibrio anguillarum.
Kumar SR; Parameswaran V; Ahmed VP; Musthaq SS; Hameed AS
Fish Shellfish Immunol; 2007 Aug; 23(2):316-26. PubMed ID: 17337208
[TBL] [Abstract][Full Text] [Related]
12. A divalent DNA vaccine based on Sia10 and OmpU induces cross protection against Streptococcus iniae and Vibrio anguillarum in Japanese flounder.
Sun Y; Zhang M; Liu CS; Qiu R; Sun L
Fish Shellfish Immunol; 2012 Jun; 32(6):1216-22. PubMed ID: 22480661
[TBL] [Abstract][Full Text] [Related]
13. Development and efficacy of an attenuated Vibrio harveyi vaccine candidate with cross protectivity against Vibrio alginolyticus.
Hu YH; Deng T; Sun BG; Sun L
Fish Shellfish Immunol; 2012 Jun; 32(6):1155-61. PubMed ID: 22484605
[TBL] [Abstract][Full Text] [Related]
14. The kinetics of antibody production in mucus and serum of European eel (Anguilla anguilla L.) after vaccination against Vibrio vulnificus: development of a new method for antibody quantification in skin mucus.
Esteve-Gassent MD; Nielsen ME; Amaro C
Fish Shellfish Immunol; 2003 Jul; 15(1):51-61. PubMed ID: 12787687
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of a bivalent protein as a vaccine against Edwardsiella anguillarum and Vibrio vulnificus in Japanese eel (Anguilla japonica).
Guo S; Hu L; Feng J; Lin P; He L; Yan Q
Microbiologyopen; 2019 Jun; 8(6):e00766. PubMed ID: 30444580
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus × O. aureus) with an inactivated Vibrio vulnificus vaccine.
Shoemaker CA; Lafrentz BR; Klesius PH
Biologicals; 2011 Nov; 39(6):424-9. PubMed ID: 21982852
[TBL] [Abstract][Full Text] [Related]
17. Immunogenic antigens of the eel pathogen Vibrio vulnificus serovar E.
Esteve-Gassent MD; Amaro C
Fish Shellfish Immunol; 2004 Sep; 17(3):277-91. PubMed ID: 15276607
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of an oral enteric coated vibrio vaccine for use in salmonid fish.
Wong G; Kaattari SL; Christensen JM
Immunol Invest; 1992 Jul; 21(4):353-64. PubMed ID: 1398784
[TBL] [Abstract][Full Text] [Related]
19. Role of the metalloprotease Vvp and the virulence plasmid pR99 of Vibrio vulnificus serovar E in surface colonization and fish virulence.
Valiente E; Lee CT; Hor LI; Fouz B; Amaro C
Environ Microbiol; 2008 Feb; 10(2):328-38. PubMed ID: 18028416
[TBL] [Abstract][Full Text] [Related]
20. Vibrio vulnificus serovar A: an emerging pathogen in European anguilliculture.
Fouz B; Larsen JL; Amaro C
J Fish Dis; 2006 May; 29(5):285-91. PubMed ID: 16677318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
